2[1]Hacke W, Schwab S, Horn M, et al. "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol, 1996, 53: 309-315.
3[2]Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory: etiology and outcome patterns. Neurology, 1998, 50: 341-350.
4[3]The National Institute of Neurological Disorders and Stroke rt-PA Stoke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med, 1995, 333: 1581-1587.
5[4]Jorgensen HS, Nakayama H, Kammersgaard LP, et al. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model.BMJ, 1999, 319: 288-289.
6[8]Moulin T, Cattin F, Crepin-Leblond T, et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology,1996, 47: 366-375.
7[9]Qureshi AI, Suarez JI, Yahia AM, et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Neurologic Critical Care , 2003, 31:272-277.
8[10]Oppenheim C, Samson Y, Manai R, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke, 2000, 31: 2175-2181.
